Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

824 ARTÍCULOS , VIENDO DEL 121 AL 135

[Pseudotumorous form of primary central nervous system vasculitis]

Kalashnikova LA, Anufriev PL, Konovalov RN, Dobrynina LA, Shabalina AA.

Zh Nevrol Psikhiatr Im S S Korsakova. 2023;123(12):141-147. doi: 10.17116/jnevro2023123121141.

Late-onset multiple acyl-CoA dehydrogenase deficiency: an insidious presentation

Rao NN, Burns K, Manolikos C, Hodge S.

BMJ Case Rep. 2023 May 22;16(5):e252668. doi: 10.1136/bcr-2022-252668.

A unique case of a fulminant clonal CD8-positive T-cell lymphoproliferative disorder with CNS involvement

Mesbah-Oskui L, Alabkal J, Alduaij W, Dhawan PS.

BMC Neurol. 2023 Sep 15;23(1):329. doi: 10.1186/s12883-023-03371-8.

A Chinese patient with POLR3A-related leukodystrophy: a case report and literature review

Sun L, Lin W, Meng H, Zhang W, Hou S.

Front Neurol. 2023 Oct 27;14:1269237. doi: 10.3389/fneur.2023.1269237. eCollection 2023.

Case report: A frameshift mutation in CLCN2-related leukoencephalopathy and retinopathy

Cheng Y, Liu X, Sun L, Ding X.

Front Genet. 2023 Nov 9;14:1278961. doi: 10.3389/fgene.2023.1278961. eCollection 2023.

De novo mutation of NAXE (APOAIBP)-related early-onset progressive encephalopathy with brain edema and/or leukoencephalopathy-1: A case report

Ding L, Huang TT, Ying GH, Wang SY, Xu HF, Qian H, Rahman F, Lu XP, Guo H, Zheng G, Zhang G.

World J Clin Cases. 2023 May 16;11(14):3340-3350. doi: 10.12998/wjcc.v11.i14.3340.

Can early-onset acquired demyelinating syndrome (ADS) hide pediatric Behcet's disease? A case report

Pozzato M, Dilena R, Rogani G, Beretta G, Torreggiani S, Lanni S, Tozzo A, Andreetta F, Cavalcante P, Triulzi F, Martinelli Boneschi F, Minoia F, Filocamo G.

Front Pediatr. 2023 Jun 23;11:1175584. doi: 10.3389/fped.2023.1175584. eCollection 2023.

White matter tract disconnection in Gerstmann's syndrome: Insights from a single case study

Ranzini M, Ferrazzi G, D'Imperio D, Giustiniani A, Danesin L, D'Antonio V, Rigon E, Cacciante L, Rigon J, Meneghello F, Turolla A, Vallesi A, Semenza C, Burgio F.

Cortex. 2023 Sep;166:322-337. doi: 10.1016/j.cortex.2023.05.016. Epub 2023 Jun 27.

Phenytoin Intoxication in a Patient Receiving a Therapeutic Dose for Postoperative Seizure Prophylaxis: A Case Study

Prasertsup W, Chomchai S, Mekavuthikul P, Phuditshinnapatra J.

Ther Drug Monit. 2023 Oct 1;45(5):573-575. doi: 10.1097/FTD.0000000000001129.

Vertebral Osteosarcoma in Two Cats-Diagnosis, Treatment, and Outcome

Santifort KM, Beukers M, Roos A, van Rijswoud B, Meertens N, Peperkamp K, Ben-Amotz R, Bergknut N.

Animals (Basel). 2023 Nov 10;13(22):3478. doi: 10.3390/ani13223478.

Combining targeted DNA repair inhibition and immune-oncology approaches for enhanced tumor control

Concannon K, Morris BB, Gay CM, Byers LA.

Mol Cell. 2023 Mar 2;83(5):660-680. doi: 10.1016/j.molcel.2022.12.031. Epub 2023 Jan 19.

Iron Metabolism in Cardiovascular Disease: Physiology, Mechanisms, and Therapeutic Targets

Sawicki KT, De Jesus A, Ardehali H.

Circ Res. 2023 Feb 3;132(3):379-396. doi: 10.1161/CIRCRESAHA.122.321667. Epub 2023 Feb 2.

Mechanisms underlying phenotypic variation in neurogenetic disorders

Burgunder JM.

Nat Rev Neurol. 2023 Jun;19(6):363-370. doi: 10.1038/s41582-023-00811-4. Epub 2023 May 18.

Understanding DNA Damage Response and DNA Repair in Multiple Myeloma

Petrilla C, Galloway J, Kudalkar R, Ismael A, Cottini F.

Cancers (Basel). 2023 Aug 17;15(16):4155. doi: 10.3390/cancers15164155.

Unleashing the Power of Synthetic Lethality: Augmenting Treatment Efficacy through Synergistic Integration with Chemotherapy Drugs

Du Y, Luo L, Xu X, Yang X, Yang X, Xiong S, Yu J, Liang T, Guo L.

Pharmaceutics. 2023 Oct 8;15(10):2433. doi: 10.3390/pharmaceutics15102433.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias